RDHL · RedHill Biopharma Ltd. · Analyst Estimates
$0.38
+0.02 (+4.13%)
At close · Nov 12
Return incl. dividend (before tax)
Q1 2022 earnings call transcript
Market Cap
$3.39M
Shares
8.89M
Volume · Nov 12
71.63K
Avg daily vol (3M)
2.05M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Analyst Estimates
Compare analyst forecasts for RedHill Biopharma Ltd. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Pull consensus estimates through the analyst estimates API or MCP →Compiled consensus
These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.
Captured 2026-09-18 04:33 UTC · Publication dates shown per estimate · 2 metric / period groups
FY ending 2023-12-31
| Metric | Low | Average | High | Analyst count |
|---|---|---|---|---|
|
Revenue
Publication date not stated |
0.00
|
0.00
|
0.00
|
0
|
Q ending 2023-06-30
| Metric | Low | Average | High | Analyst count |
|---|---|---|---|---|
|
Revenue
Publication date not stated |
0.00
|
0.00
|
0.00
|
0
|